FARGO, N.D. (AP) — Fargo biotech company Aldevron has been chosen to produce cancer vaccines developed by a Boston-area research company that plans to move most of its operations to North Dakota.
The Forum newspaper reports (http://bit.ly/RzuBU8Z) that the DNA-based vaccines have showed promise in animal studies in suppressing lung and breast cancers.
CureLab Oncology will keep a lab and office in Canton, Mass., but it plans to move most of its operations to North Dakota, possibly in Fargo or in Grand Forks. CureLab also is collaborating with Avianax, a biotech company at the University of North Dakota in Grand Forks.
CureLab CEO Alex Schneider says the company will bring a few people to North Dakota but plans to hire local college and university graduates.